Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

NCT02768389 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Brain Tumor

Interventions

DRUG: Bevacizumab
BEHAVIORAL: Modified Atkins Diet

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]